DOI: https://doi.org/10.22141/2307-1257.0.3.09.2014.76073

The Use of Extracts of Goldenrod (Solidago Virgaurea L.) for the Treatment of Diseases of the Urinary Tract

A.V. Savustyanenko

Abstract


This review examines the pharmacological and clinical data on the use of extracts of goldenrod (Solidago virgaurea L.) for the treatment of diseases of the urinary system. Goldenrod extracts exhibit 6 major pharmacological effects: anti-bacterial, anti-inflammatory, immunomodulatory, antispasmodic, analgesic and diuretic. Results of open non-randomized studies have shown the possibility of using extracts of goldenrod for the treatment of infectious (cystitis) and functional (irritable bladder) urinary tract di­seases. Evaluating the effectiveness of the treatment as «good» and «very good», which gave doctors and patients at the end of therapy, reached 90–100% level. For the manifestation of the therapeutic effect of the drug it was enough to take it 2–4 weeks. Side effects were rare — in larger studies, their frequency did not exceed 0.3% and they were of mild severity and were limited mainly to gastro-intestinal disorders and allergic reactions. Overall, treatment was well tolerated.
Conclusions. Extracts of goldenrod (Solidago virgaurea L.) can be used in the complex therapy of diseases of the urinary tract to increase the effectiveness of therapy, to accelerate the recovery of patients and to reduce the likelihood of relapses.


Keywords


goldenrod; cystitis; irritable bladder

References


Goldenrod // Herbalpedia. — www.herbworld.com

European Goldenrod // Herbal Medicines. —4th edition. — 2013. — 928 p.

Assessment report on Soidago virgaurea L. herba // European Medicines Agency. — 2008.

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society / Gupta K., Hooton T.M., Naber K.G. et al. // Clin. Infect. Dis. — 2011. — V. 52, № 5. — P. e103 — e120; doi: 10.1093/cid/ciq257.

Brantner A. The antimicrobial activity of Solidago-containing phytourologica // Drogen-report. — 1999. — V. 12. — P. 27-28.

Thiem B., Goślińska O. Antimicrobial activity of Solidago virgaurea L. from in vitro cultures // Fitoterapia. — 2002. — V. 73, № 6. — P. 514-516.

Kołodziej B., Kowalski K., Kędzia B. Antibacterial and antimutagenic activity of extracts aboveground parts of three Solidago species: Solidago virgaurea L., Solidago canadensis L. and Solidago gigantea Ait. // Journal of Medicinal Plants Research. — 2011. — V. 5, № 31. — P. 6770-6779.

Strehl E., Schneider W., Elstner E.F. Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. — 1995. — V. 45, № 2. — P. 172-173.

Kalemba D. Constituents and biological activity of the essential oils of some Solidago and Artemisia species // Scientific Papers Technical University of Lodz. — 2000. — V. 857. — P. 1-118.

Pepeljnjak S., Kustrak D., Vukusic I. Investigation of the antimycotic activity of Solidago virgaurea and Solidago gigantea extracts // Pharm. Pharmacol. Lett. — 1998. — V. 8. — P. 85-86.

Triterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast-hyphal conversion / Laurençon L., Sarrazin E., Chevalier M. et al. // Phytochemistry. — 2013. — V. 86. — P. 103-111.

Morris C.J. Carrageenan-induced paw edema in the rat and mouse // Methods Mol. Biol. — 2003. — V. 225. — P. 115-121.

Study of the anti-inflammatory activity of Populus tremula, Solidago virgaurea and Fraxinus excelsior / El-Ghazaly M., Khayyal M.T., Okpanyi S.N., Arens-Corell M. // Arzneim-Forsch/Drug Res. — 1992. — V. 42. — P. 333-336.

Wagener H.H. Zur Pharmakologie eines Solidago-Extrakt-haltigen Venenmittels // Arzneimittelforschung. — 1966. — V. 16. — P. 859-866.

Echtes Goldenrutenkraut als entzündungshemmende Droge / Melzig M.F., Löser B., Bader G., Papsdorf G. // Z. Phytother. — 2000. — V. 21. — P. 67-70.

Meyer B., Schneider W., Elstner E.F. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. — 1995. — V. 45, № 2. — P. 174-176.

Immunomodulatory and antitumoral effects of triterpenoid saponins / Plohmann B., Bader G.T., Hiller K., Franz G. // Pharma­zie. — 1997. — V. 12. — P. 953-957.

Immunmodulatorische und antitumorale Aktivität von Tri­terpensaponinen aus Solidago virgaurea L. / Plohmann B., Franz G., Bader G., Hiller K. // Drogenreport. — 1999. — V. 12. — P. 29-30.

Immunobiological activity of a new benzyl benzoate from the aerial part sof Solidago virgaurea var. gigantea / Choi S.Z., Choi S.U., Bae S.Y. et al. // Arch. Pharm. Res. — 2005. — V. 28. — P. 49-54.

Westendorf J., Vahlensieck W. Spasmolytische und kontraktile Einflüsse eines pflanzlichen Kombinations-präparates auf die glatte Muskulatur des isolierten Meerschweinchendarms // Arzneim-Forsch/Drug Res. — 1981. — V. 31. — P. 40-43.

Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction / Borchert V.E., Czyborra P., Fetscher C. et al. // Naunyn Schmiedebergs Arch. Pharmacol. — 2004. — V. 369, № 3. — P. 281-286.

Metzner J., Hirschelmann R., Hiller K. Antiphlogistische und analgetische Wirkungen von Leiocarposid, einem phenolischen Bisglucosid aus Solidago virgaurea L. // Pharmazie. — 1984. — V. 39. — P. 869-870.

Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assays / Sampson J.H., Phillipson J.D., Bowery N.G. et al. // Phytother Res. — 2000. — V. 14, № 1. — P. 24-9.

Melzig, M.F. New aspects for understanding the mechanism of the aquaretic effects of birch leaves and goldenrod // Zeitschrift fur Phytotherapie. — 2000. — V. 21, № 4. — P. 193-196.

Klinisch-Experimentelle Studie Nr 23223. P 1. 1992. Bioforce AG.

Klinisch-Experimentelle Studie Nr 23223. P 2. 1992. Bioforce AG.

Schmitt M. Echte Goldrute normaliesiert die Reizblase. Effective und nebenwirkungsarme Behandlung abakterieller Cystiden // TW Urologie Nephrologie. — 1996. — V. 8. — P. 133-135.

Klinische Anwendungsbeobachtungen zur Wirksamkeit und Sicherheit bei Monographie-konformem Einsatz eines Goldruten-extrakt-Präparates / Laszig R., Smiszek R., Stammwitz U. et al. // Drogenreport. — 1999. — V. 12. — P. 38-40.

Pfannkuch A., Stammwitz U. Wirksamkeit und Verträglichkeit eines monographiekonformen Goldrutenkraut-Extraktes bei Patienten mit Reizblase // Ztschr. Phytother. — 2002. — V. 23. — P. 20-25.

Schakau D. Solidago Steiner® Tabletten. Solidago Steiner® Lösung und Harntee Steiner® // Portfolio-Schulung. — Januar, 2014.




Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта